{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:57:31Z","timestamp":1760061451200,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11307-018-1226-7","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T16:22:39Z","timestamp":1529338959000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-6705","authenticated-orcid":false,"given":"Azadeh","family":"Abravan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Astrid","family":"Eide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayca Muftuler","family":"L\u00f8ndalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5slaug","family":"Helland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"Malinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"issue":"6","key":"1226_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/cncr.21324","volume":"104","author":"G Delaney","year":"2005","unstructured":"Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104(6):1129\u20131137","journal-title":"Cancer"},{"issue":"4","key":"1226_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc3007","volume":"11","author":"AC Begg","year":"2011","unstructured":"Begg AC, Stewart FA, Vens C (2011) Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 11(4):239\u2013253","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1226_CR3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ijrobp.2007.11.070","volume":"71","author":"A Baardwijk van","year":"2008","unstructured":"van Baardwijk A, Bosmans G, Boersma L, Wanders S, Dekker A, Dingemans AMC, Bootsma G, Geraedts W, Pitz C, Simons J, Lambin P, de Ruysscher D (2008) Individualized radical radiotherapy of non\u2013small-cell lung cancer based on normal tissue dose constraints: a feasibility study. Int J Radiat Oncol Biol Phys 71(5):1394\u20131401","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1226_CR4","first-page":"851","volume-title":"Biochemistry","author":"JM Berg","year":"2006","unstructured":"Berg JM, Tymoczko JL, Stryer L (2006) Each organ has a unique metabolic profile. In: Biochemistry. W.H.Freeman & Co Ltd, New York, pp 851\u2013854"},{"issue":"5","key":"1226_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11307-007-0100-9","volume":"9","author":"C Fan","year":"2007","unstructured":"Fan C, Hernandez-Pampaloni M, Houseni M, Chamroonrat W, Basu S, Kumar R, Dadparvar S, Torigian DA, Alavi A (2007) Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol 9(5):300\u2013307","journal-title":"Mol Imaging Biol"},{"key":"1226_CR6","doi-asserted-by":"crossref","unstructured":"Dudek A, Mahaseth H (2005) Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Cancer Invest\u00a023(3):193\u2013200","DOI":"10.1081\/CNV-200055949"},{"issue":"3","key":"1226_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1164\/ajrccm.156.3.9701122","volume":"156","author":"A Colasante","year":"1997","unstructured":"Colasante A, Mascetra N, Brunetti M et al (1997) Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors. Am J Respir Crit Care Med 156(3):968\u2013973","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1226_CR8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.V77.3.472.472","volume":"77","author":"ML Patchen","year":"1991","unstructured":"Patchen ML, MacVittie TJ, Williams JL, Schwartz GN, Souza LM (1991) Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 77(3):472\u2013480","journal-title":"Blood"},{"key":"1226_CR9","doi-asserted-by":"crossref","unstructured":"Ramadori G, Van Damme J, Rieder H, Meyer zum B\u00fcschenfelde KH (1988) Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 p and tumor necrosis factor-a. Eur. J. Immuno 18:1259\u20131264","DOI":"10.1002\/eji.1830180817"},{"issue":"1","key":"1226_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijrobp.2015.09.022","volume":"94","author":"MP Deek","year":"2016","unstructured":"Deek MP, Benenati B, Kim S, Chen T, Ahmed I, Zou W, Aisner J, Jabbour SK (2016) Thoracic vertebral body irradiation contributes to acute hematologic toxicity during chemoradiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 94(1):147\u2013154","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"1226_CR11","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1200\/JCO.2007.15.3312","volume":"26","author":"A Fairchild","year":"2008","unstructured":"Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, Cheung P, Chow E (2008) Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 26(24):4001\u20134011","journal-title":"J Clin Oncol"},{"issue":"3","key":"1226_CR12","doi-asserted-by":"publisher","first-page":"e59314","DOI":"10.1371\/journal.pone.0059314","volume":"8","author":"X Chen","year":"2013","unstructured":"Chen X, Liu Y, R\u00f8e OD, Qian Y, Guo R, Zhu L, Yin Y, Shu Y (2013) Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review. PLoS One 8(3):e59314","journal-title":"PLoS One"},{"issue":"11","key":"1226_CR13","first-page":"1596","volume":"42","author":"RJ Hicks","year":"2001","unstructured":"Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie A, Matthews JP, Ball DL (2001) 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42(11):1596\u20131604","journal-title":"J Nucl Med"},{"issue":"1","key":"1226_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.lungcan.2013.03.015","volume":"81","author":"JF Jim\u00e9nez-Bonilla","year":"2013","unstructured":"Jim\u00e9nez-Bonilla JF, Quirce R, Mart\u00ednez-Rodr\u00edguez I, Banzo I, Rubio-Vassallo AS, del Castillo-Matos R, Ortega-Nava F, Mart\u00ednez-Amador N, Ib\u00e1\u00f1ez-Bravo S, Carril JM (2013) Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET\/CT. Lung Cancer 81(1):71\u201376","journal-title":"Lung Cancer"},{"issue":"6","key":"1226_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2214\/ajr.169.6.9393189","volume":"169","author":"BA Gordon","year":"1997","unstructured":"Gordon BA, Flanagan FL, Dehdashti F (1997) Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR Am J Roentgenol 169(6):1675\u20131680","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"1226_CR16","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s00330-016-4568-z","volume":"27","author":"JW Lee","year":"2016","unstructured":"Lee JW, Seo KH, Kim E-S, Lee SM (2016) The role of 18F-fluorodeoxyglucose uptake of bone marrow on PET\/CT in predicting clinical outcomes in non-small cell lung cancer patients treated with chemoradiotherapy. Eur Radiol 27(5):1912\u20131921","journal-title":"Eur Radiol"},{"issue":"4","key":"1226_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ijrobp.2011.09.048","volume":"83","author":"BS Rose","year":"2012","unstructured":"Rose BS, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell LK (2012) Correlation between radiation dose to 18F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 83(4):1185\u20131191","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1226_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ijrobp.2012.04.044","volume":"85","author":"Y Liang","year":"2013","unstructured":"Liang Y, Bydder M, Yashar CM, Rose BS, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell LK (2013) Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys 85(2):406\u2013414","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"1226_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12032-016-0789-x","volume":"33","author":"P Franco","year":"2016","unstructured":"Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Cassoni P, Arena V, Bustreo S, Faletti R, Rondi N, Morino M, Ricardi U (2016) Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients. Med Oncol 33(7):72","journal-title":"Med Oncol"},{"issue":"4","key":"1226_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ijrobp.2015.12.006","volume":"94","author":"BS Rose","year":"2016","unstructured":"Rose BS, Jee KW, Niemierko A, Murphy JE, Blaszkowsky LS, Allen JN, Lee LK, Wang Y, Drapek LC, Hong TS, Wo JY (2016) Irradiation of FDG-PET-defined active bone marrow subregions and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. Int J Radiat Oncol Biol Phys 94(4):747\u2013754","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1226_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7150\/jca.11348","volume":"6","author":"M Yagi","year":"2015","unstructured":"Yagi M, Froelich J, Arentsen L, Shanley R, Ghebre R, Yee D, Hui S (2015) Longitudinal FDG-PET revealed regional functional heterogeneity of bone marrow, site-dependent response to treatment and correlation with hematological parameters. J Cancer 6(6):531\u2013537","journal-title":"J Cancer"},{"issue":"4","key":"1226_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijrobp.2016.11.033","volume":"97","author":"SS Noticewala","year":"2017","unstructured":"Noticewala SS, Li N, Williamson CW et al (2017) Longitudinal changes in active bone marrow for cervical cancer patients treated with concurrent chemoradiation therapy. Int J Radiat Oncol Biol Phys 97(4):797\u2013805","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1226_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","volume":"79","author":"JA Hayman","year":"2011","unstructured":"Hayman JA, Callahan JW, Herschtal A, Everitt S, Binns DS, Hicks RJ, Mac Manus M (2011) Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging. Int J Radiat Oncol Biol Phys 79(3):847\u2013852","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"1226_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12149-009-0286-9","volume":"23","author":"K Inoue","year":"2009","unstructured":"Inoue K, Goto R, Okada K, Kinomura S, Fukuda H (2009) A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Ann Nucl Med 23(7):643\u2013649","journal-title":"Ann Nucl Med"},{"key":"1226_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ctro.2017.04.002","volume":"4","author":"A Abravan","year":"2017","unstructured":"Abravan A, Eide HA, Knudtsen I, L\u00f8ndalen A, Helland \u00c5, Malinen E (2017) Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib. Clin Transl Radiat Oncol 4:57\u201363","journal-title":"Clin Transl Radiat Oncol"},{"key":"1226_CR26","doi-asserted-by":"publisher","unstructured":"Eide HA, Halvorsen AR, Sandhu V, et al. (2016) Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease. Clin Trans Immunol 5(11):e109. https:\/\/doi.org\/10.1038\/cti.2016.65","DOI":"10.1038\/cti.2016.65"},{"issue":"5","key":"1226_CR27","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","volume":"31","author":"P Mauch","year":"1995","unstructured":"Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL, Deeg HJ (1995) Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 31(5):1319\u20131339","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1226_CR28","first-page":"303","volume-title":"Radiobiology for the radiologist","author":"EJ Hall","year":"2006","unstructured":"Hall EJ, Giaccia AJ (2006) Dose\u2013response relationships for model normal tissues. In: Mitchell CW (ed) Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia, pp 303\u2013326"},{"issue":"4","key":"1226_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S (2013) Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 105(4):256\u2013265","journal-title":"J Natl Cancer Inst"},{"key":"1226_CR30","doi-asserted-by":"crossref","unstructured":"Heylmann D, R\u00f6del F, Kindler T, Kaina B (2014) Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells. Biochim Biophys Acta\u00a01846(1):121\u2013129","DOI":"10.1016\/j.bbcan.2014.04.009"},{"issue":"12","key":"1226_CR31","first-page":"2026","volume":"41","author":"T Higashi","year":"2000","unstructured":"Higashi T, Fisher SJ, Brown RS, Nakada K, Walter GL, Wahl RL (2000) Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med 41(12):2026\u20132035","journal-title":"J Nucl Med"},{"key":"1226_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nm.2217","volume":"16","author":"MA Ryan","year":"2010","unstructured":"Ryan MA, Nattamai KJ, Xing E, Schleimer D, Daria D, Sengupta A, K\u00f6hler A, Liu W, Gunzer M, Jansen M, Ratner N, le Cras TD, Waterstrat A, van Zant G, Cancelas JA, Zheng Y, Geiger H (2010) Pharmacological inhibition of EGFR signaling enhances G-CSF\u2013induced hematopoietic stem cell mobilization. Nat Med 16:1141\u20131146","journal-title":"Nat Med"},{"issue":"3","key":"1226_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nm.3070","volume":"19","author":"PL Doan","year":"2013","unstructured":"Doan PL, Himburg HA, Helms K, Russell JL, Fixsen E, Quarmyne M, Harris JR, Deoliviera D, Sullivan JM, Chao NJ, Kirsch DG, Chute JP (2013) Epidermal growth factor regulates hematopoietic regeneration following radiation injury. Nat Med 19(3):295\u2013304","journal-title":"Nat Med"},{"key":"1226_CR34","doi-asserted-by":"crossref","unstructured":"Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos JC Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1(9):725\u2013731","DOI":"10.1016\/S1074-7613(94)80014-6"},{"key":"1226_CR35","doi-asserted-by":"crossref","unstructured":"Fletcher EVM, Love-Homan L, Sobhakumari A, et al. (2013) Epidermal growth factor receptor inhibition induces pro-inflammatory cytokines via NOX4 in head and neck cancer cells. Mol Cancer Res","DOI":"10.1158\/1541-7786.MCR-13-0187"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-018-1226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-018-1226-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-018-1226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T22:20:09Z","timestamp":1661466009000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-018-1226-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1007\/s11307-018-1226-7","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"type":"print","value":"1536-1632"},{"type":"electronic","value":"1860-2002"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"18 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics. A written informed consent was received from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}